Atlas Trials

Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF

Clinical trial NCT03043651 · TERMINATED

Trial details

NCT number
NCT03043651
Sponsor
United Therapeutics
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Pulmonary Hypertension Associated With HFpEF
Start date
2018-01-30
Primary completion
2020-03-02
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.